Skip to content

Insider · CIK 0001969388

Kenneth A. Stauderman

officer

Files at CALC (CalciMedica, Inc.). First filing Jul 2, 2025, latest Jul 29, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 1
$5,810 bought, $3,650 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CALC: CalciMedica, Inc.

CALCOct 9, 2026 · close 1.27

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
42Moderate
CALCbuy 4
CalciMedica, Inc.
$3,960
1,000 shares
+8%+159% from low-26% from high
35Weak
CALCsell
CalciMedica, Inc.
$3,650
1,000 shares
-100%+166% from low-24% from high
56Moderate
CALCbuy 4
CalciMedica, Inc.
$1,850
1,000 shares
-+9% from low-69% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 24, 2026CALC
CalciMedica, Inc.
AGrant or award
Employee Stock Option (Right to Buy)derivative
+180,000$0.00$0180,00014 d ago
Jul 25, 2025CALC
CalciMedica, Inc.
SOpen-market sale
Common Stockindirect: By Spouse
-1,000$3.65$3,6500Jul 29, 2025
Jul 28, 2025CALC
CalciMedica, Inc.
POpen-market purchase
Common Stock
+1,000$3.96$3,96012,944Jul 29, 2025
Jul 1, 2025CALC
CalciMedica, Inc.
POpen-market purchase
Common Stockindirect: By Spouse
+1,000$1.85$1,8501,000Jul 2, 2025
Jun 24, 2025CALC
CalciMedica, Inc.
AGrant or award
Employee Stock Option (Right to Buy)derivative
+47,125$0.00$047,125Jun 26, 2025
Apr 23, 2025CALC
CalciMedica, Inc.
AGrant or award
Employee Stock Option (Right to Buy)derivative
+125,000$0.00$0125,000Apr 25, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kenneth A. Stauderman: insider trades and track record | InsiderTell